Maini's new catchy dance single Hold Me will be released worldwide on May 7th 2013. Hold Me music video will be promoted to MTV and all over the USA by Trilogy Music Group in Hollywood. The music video is directed by W.A. Henderson from Los Angeles and the label behind the release is Reya music from Sweden. Maini has, as always, written the music, while the lyrics are by Gary Cornman from the USA and the remix is by Carsten Lehmann from Germany. The beautiful Hold Me music video that you can watch time after time stars Mali Monae and Michael Martinez from Los Angeles, USA.
HOLD ME Lyrics
Music: Maini Sorri
Lyrics: Gary Cornman
1. I'm feeling really down
I hope you come around.
Hold me real tight with all your might.
2. Hold me every way
Hold me throughout the day.
Feeling upside down about to drown.
Chore: Hold me, just hold me
Don't let me sit here alone
you can just pick up your phone
Hold me, just hold me
I need that you will stop on by
you can dry a teary eye.
Hold me.
3. Just hold me in this room
to help me out of gloom.
Hold before you go I feel so low.
4. I want your loving hugs
just like addictive drugs
never got enough of hugging stuff.
Chore: Hold me, just hold me
Don't let me sit here alone
you can just pick up your phone
Hold me, just hold me
I need that you will stop on by
you can dry a teary eye.
Hold me.
Hold me in the night and make it bright
reaching out for you to get me out of blue.
Hold me.
5. I'm feeling really down
I hope you come around.
Hold me real tight with all your might.
6. Hold me every way
Hold me throughout the day.
Feeling upside down about to drown.
Chore: Hold me, just hold me
Don't let me sit here alone
you can just pick up your phone
Hold me, just hold me
I need that you will stop on by
you can dry a teary eye.
Chore: Hold me, just hold me
Don't let me sit here alone
you can just pick up your phone
Hold me, just hold me
I need that you will stop on by
you can dry a teary eye.
Addiction can destroy careers and ruin lives. It can be devastating to watch a loved one descend into addiction, and family members often can’t understand why an addict continues to use drugs or alcohol despite the ruinous consequences.
In a series of new videos at besmartbewell.com/addiction, leading experts explain how addiction affects the brain and offer insight into why it is so hard for addicts to stop using drugs and alcohol.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61017-be-smart-be-well-explores-the-science-of-addiction
Upsher-Smith Laboratories, Inc. [http://www.upsher-smith.com] today announced that its epilepsy-focused educational website, Epilog.us [http://www.Epilog.us], now features a panel discussion of leading experts on the role of rational polytherapy in the treatment of patients with epilepsy, led by Dr. Barry Gidal, Professor of Pharmacy and Neurology/Division Chair, University of Wisconsin. Dr. Gidal also brings forward discussion on the mechanism of action of specific antiepileptic drugs (AEDs). Additional topics include: AED pharmacokinetics; patient adherence and AEDs; and drug interactions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59891-upsher-smith-epilog-us-pharmacodynamics-of-antiepileptic-drugs-aeds
Iroko Pharmaceuticals, LLC, a Philadelphia-based pharmaceutical company focused on the development and commercialization of innovative therapeutic products, today announced the opening of its new environmentally friendly corporate headquarters in Philadelphia’s Navy Yard Corporate Center. This milestone is part of the Company’s long-term growth plan as it advances its late-stage pipeline of lower dose submicron non-steroidal anti-inflammatory drugs (NSAIDs) towards commercialization.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58559-iroko-pharmaceuticals-opens-philadelphia-headquarters-hq
OptiNose US Inc. today announced results of a study testing delivery of the migraine medicine sumatriptan with a novel device using OptiNose breath powered Bi-Directional™ nasal technology. In a direct comparison of drug absorption, the study found that OptiNose's sumatriptan product sent 62% more drug into the blood in the critical first 15 minutes than Imitrex® nasal spray (AUC 0-15 = 1.69 ng*hr/mL and 1.04 ng*hr/mL, respectively). The OptiNose technology achieved this improved effect despite delivering 20% less drug into the nose (16mg) than the Imitrex® liquid nasal spray (20mg).
To view Multimedia News Release, go to http://www.multivu.com/players/English/57713-optinose-innovative-breath-powered-nasal-delivery-technology-delivers-drugs-to-treat-variety-of-medical-conditions